FindTrial
Sign In

Assessing the Impact of Continuous Audio-Visual Feedback in Deep Inspiration Breath Hold (DIBH) for Breast Cancer Radiotherapy

Evaluation of Effectiveness of Continuous Audio and Visual Feedback (A-V aid) in Deep Inspiration Breath Hold (DIBH) Technique in Patients Receiving Radiotherapy for Breast Cancer - ECAV-DIBH

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084225
Enrollment
130
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All 3DCRT left sided breast cancer patients will be included. 2. All patients will be included with their informed consent. 3. Moderate Hypo fractionated adjuvant RT (40 Gy in 15 fractions) patients will be included.

Exclusion criteria

Exclusion criteria: 1. Patients those who are unable to understand the DIBH instructions. 2. Major chest wall deformation. 3. Patients having pulmonary diseases such as COPD, asthma, active tuberculosis.

Design outcomes

Primary

MeasureTime frame
To determine the difference in the number of patients capable of performing DIBH with the support of audio and visual aids compared to standard DIBH training.Timepoint: 3 YEARS—

Secondary

MeasureTime frame
To assess the impact of audio and visual aids on: 1. Simulation time. 2. Treatment time. 3. Reducing the number of actual demonstration sessions required. 4. Dose comparisons between organs at risk (OARs), specifically the heart and lungs.Timepoint: 3 YEARS—

Countries

India

Contacts

Public ContactSubhabrat Dash

Homi Bhabha Cancer Hospital and Research Center

dashsubhabrat@gmail.com7978695219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026